We are live on ! Find out more
AE

Axon Enterprise Portfolio holdings

AUM $19.1M
1-Year Est. Return 8.75%
This Fund
S&P 500
This Quarter Est. Return
-23.57%
1 Year Est. Return
-8.75%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$18.1M
AUM Growth
-$9.16M
Cap. Flow
-$3M
Cap. Flow %
-16.64%
Top 10 Hldgs %
100%
Holding
1
New
Increased
Reduced
1
Closed

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
CLBT icon
Cellebrite
CLBT
+$3M

Sector Composition

Rank Sector Weight
1 Technology 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CLBT icon
1
Cellebrite
CLBT
$3.07B
$18.1M 100%
1,310,013
-199,328
-13% -$3M

Similar funds

Axon Enterprise's Q1 2026 Portfolio in Review

As of Q1 2026, Axon Enterprise held 1 position worth $18.1M, down 34% from $27.2M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Axon Enterprise withdrew a net $3M in Q1 2026, reducing 1 holding. Its largest reduction was Cellebrite, cutting an estimated $3M.

By sector, the portfolio is most concentrated in Technology at 100% of assets, unchanged from a quarter earlier.

  • Axon Enterprise's biggest Q1 2026 reduction was Cellebrite, cutting an estimated $3M.
  • Axon Enterprise's ten largest holdings make up 100% of its $18.1M portfolio in Q1 2026.
  • Axon Enterprise opened 0 new positions and closed 0 in Q1 2026.
  • Axon Enterprise's portfolio value fell 34% quarter-over-quarter to $18.1M.

Based on Axon Enterprise's 13F filing for Q1 2026, filed 15 May 2026.